Skip to main content
. 2019 Oct-Dec;15(4):430–435. doi: 10.4183/aeb.2019.430

Table 4.

Comparison of pro and anti-inflammatory marker levels in each of the MetS criteria

Parameters Hypertriglyceridemia Hypertension Hyperglycemia Low HDL-C Abdominal obesity
Positive
(n: 72)
Negative
(n: 36)
P
Value
Positive
(n: 27)
Negative
(n: 81)
P
Value
Positive
(n: 54)
Negative
(n: 54)
P
Value
Positive
(n: 75)
Negative
(n: 33)
P
Value
Positive
(n: 54)
Negative
(n: 54)
P
Value
Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR)
TNF-α
(pg/mL)
6.84
(11.5)
8.27
(5.2)
0.263 0.37
(13.0)
8.36
(6.33)
0.006 1.6
(12.3)
8.7
(4.6)
< 0.001 5.8
(11.9)
9.1
(5.0)
0.029 1.78
(10.1)
8.7
(5.0)
< 0.001
IL-6
(pg/mL)
59.65
(99.9)
0.0
(57.4)
0.001 77.9
(81.4)
16.1
(64.1)
< 0.001 74.7
(81.4)
0.00
(59.7)
< 0.001 57.4
(84.6)
0.0
(55.8)
< 0.001 69.5
(85.5)
0.0
(59.7)
< 0.001
Adiponectin
(ng/mL)
7.1
(5.0)
9.77
(8.5)
0.029 8.65
(8.62)
7.6
(5.9)
0.458 7.0
(6.0)
8.3
(5.7)
0.191 7.3
(6.0)
8.4
(4.7)
0.162 7.7 (6.0) 8.3
(5.6)
0.253
Apo-A1 (mg/dL) 121.0
(28.0)
147.5
(42.0)
< 0.001 117.0
(23.0)
133.0
(37.3)
< 0.001 117.0
(22.0)
147.5
(34.3)
< 0.001 120.0
(26.0)
161.0
(29.8)
< 0.001 117.0
(22.5)
146.5
(32.3)
< 0.001
Apo-B
(mg/dL)
104.0
(30.4)
80.8
(28.2)
< 0.001 98.2
(26.1)
94.0
(34.5)
0.800 102.0
(27.0)
89.9
(34.1)
0.154 101.0
(29.4)
82.3
(35.6)
0.016 98.6
(28.6)
92.5
(34.8)
0.311
Apo-B/Apo- A1 ratio 0.85
(0.29)
0.57
(0.24)
< 0.001 0.84
(0.29)
0.71
(0.34)
0.031 0.85
(0.27)
0.60
(0.33)
< 0.001 0.84
(0.28)
0.52
(0.19)
< 0.001 0.84
(0.24)
0.61
(0.36)
< 0.001
Fibrinogen (gr/dL) 3.24
(0.75)
3.0
(0.6)
0.037 3.34
(1.11)
3.1
(0.68)
0.059 3.36
(1.0)
3.0
(0.56)
< 0.001 3.22
(0.84)
3.1
(0.55)
0.104 3.35
(1.15)
3.0
(0.57)
< 0.001
C3
(gr/L)
2.15
(0.97)
1.7
(0.63)
0.001 2.3
(0.91)
1.81
(0.75)
0.002 2.32
(0.8)
1.67
(0.6)
< 0.001 2.16
(0.93)
1.71
(0.6)
0.004 2.28
(0.88)
1.68
(0.59)
< 0.001

Abbreviations: See Table1. *Mann-Whitney U test to compare two groups was used in this table.